Every material Form 8-K Quanex Building Products filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Quanex reported fourth-quarter and fiscal 2025 results for the period ended October 31, 2025. Fourth-quarter net sales were $489.8 million, down 0.5% from a year earlier, while net income swung to $19.6 million from a loss of $13.9 million, but the full year showed a $250.8 million net loss driven by a $302.3 million goodwill impairment. The company declined to issue formal 2026 guidance, saying fiscal 2026 could be flat with fiscal 2025 on revenue and EBITDA and that it will revisit guidance with its first-quarter results.
Q4 net sales $489.8 million vs $492.2 million a year earlier; Q4 net income $19.6 million, or $0.43 diluted EPS, vs a $13.9 million loss
Full-year net loss of $250.8 million, including a $302.3 million goodwill impairment charge; full-year net sales rose 43.8% to $1.84 billion, mainly from the Tyman acquisition
Q4 adjusted diluted EPS $0.83 vs $0.82; full-year free cash flow $102.3 million and $75 million of bank debt repaid in 2025
No official 2026 guidance; management says fiscal 2026 could be flat with fiscal 2025 on revenue and EBITDA, with the first half likely more challenged
Quanex Building Products named Mary K. Lawler, Senior Vice President and Chief Human Resources Officer of Illinois Tool Works, as a director effective November 1, 2025. The appointment adds a new board member whose term runs to the 2026 annual shareholder meeting, and the filing describes it as routine board refresh rather than a change in company operations.
Mary K. Lawler, age 60, appointed to the Board by the Board of Directors effective November 1, 2025
Term ends at the Company's next annual shareholder meeting, to be held in 2026
Lawler joins the Compensation & Management Development and Nominating & Corporate Governance Committees
Receives an annual Restricted Stock Unit grant on November 3, 2025 under standard director compensation practices
Quanex Building Products appointed Gabriela Garcia as Vice President, Chief Accounting Officer and principal accounting officer, effective October 20, 2025, replacing Karen Ettredge in the principal accounting officer role while Ettredge remains Controller. The filing sets Garcia's base salary at $360,000 with an annual incentive target of 45% of base salary, and the company describes her as having over 25 years of accounting experience, most recently at Rayonier Advanced Materials.
Gabriela Garcia appointed Vice President, Chief Accounting Officer, effective October 20, 2025
Karen Ettredge remains Controller but no longer serves as principal accounting officer
Offer letter sets base salary at $360,000 and annual incentive target at 45% of base salary; long-term incentive target to be determined later
Garcia previously served as Chief Accounting Officer and Corporate Controller at Rayonier Advanced Materials from 2020 to 2025
Quanex reported net sales of $495.3 million for the quarter ended July 31, 2025, up 76.7% from a year earlier, mainly due to the Tyman acquisition. A $302.3 million non-cash goodwill impairment tied to the re-segmentation of the business drove a net loss of $276.0 million, or $6.04 per diluted share, compared with net income of $25.4 million a year earlier. The company also updated its fiscal 2025 guidance to about $1.82 billion in net sales and about $235 million in Adjusted EBITDA.
Q3 net sales $495.3 million, up from $280.3 million; excluding Tyman, sales rose 1.4%
Net loss of $276.0 million, or $6.04 per diluted share, versus $0.77 per share a year earlier
Adjusted diluted EPS $0.69 versus $0.81 a year earlier; Adjusted EBITDA $70.3 million
Fiscal 2025 guidance: net sales of approximately $1.82 billion and Adjusted EBITDA of approximately $235 million
Quanex reported second-quarter results for the three months ended April 30, 2025, with net sales up 70% to $452.5 million, mostly from the Tyman acquisition, while diluted EPS fell to $0.44 from $0.46. The company reaffirmed its fiscal 2025 guidance and raised its cost synergy target to about $45 million, up from $30 million.
Net sales were $452.5 million versus $266.2 million a year earlier; Tyman contributed $190.1 million.
Diluted EPS was $0.44 versus $0.46; adjusted diluted EPS was $0.60 versus $0.73.
Fiscal 2025 guidance reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million.
Cost synergy target raised to about $45 million; the company repurchased about $23.5 million of stock in the quarter.
Quanex reported a fiscal first-quarter net loss of $14.9 million, or $0.32 per diluted share, versus net income of $6.2 million, or $0.19 per share, a year earlier, while net sales rose 67.3% to $400.0 million on the Tyman acquisition. The company reaffirmed its fiscal 2025 guidance of $1.84 billion to $1.86 billion in net sales and $270 million to $280 million in Adjusted EBITDA, and it said it has repaid $65 million of debt since closing the Tyman deal on August 1, 2024.
Net sales were $400.0 million for the three months ended January 31, 2025, up from $239.2 million; Tyman contributed $175.7 million, and excluding Tyman, net sales declined 6.2%.
Net loss was $14.9 million, or $0.32 per diluted share, compared with net income of $6.2 million, or $0.19 per share; restructuring charges were $7.9 million.
Adjusted diluted EPS was $0.19, down from $0.25, and Adjusted EBITDA was $38.5 million, up from $19.3 million.
Fiscal 2025 guidance was reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million; total debt was $764.3 million as of January 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Quanex Building Products filing is on SEC EDGAR ↗. 8-K briefs of other companies →